David J. Endicott Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David J. Endicott.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David J. Endicott. David J. Endicott is CVP and President, AGN Med in ALLERGAN INC ($AGN) and Pres., Hospira Medical Devices in HOSPIRA INC ($HSP) and Director in Orexigen Therapeutics, Inc. ($OREX) and Director in Zeltiq Aesthetics Inc ($ZLTQ).
Latest Insider Trading Transactions of David J. Endicott
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGN, HSP, OREX, ZLTQ
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18 2017 | OREX | Orexigen Therapeut ... | Endicott David J. | Director | Option Exercise | A | 2.88 | 5,000 | 14,400 | 5,000 | |
| Apr 28 2017 | ZLTQ | Zeltiq Aesthetics ... | Endicott David J. | Director | Sell | J | 0.00 | 16,132 | 0 | 0 | 16.1 K to 0 (-100.00 %) |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Endicott David J. | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 | |
| Jun 23 2016 | ZLTQ | Zeltiq Aesthetics ... | Endicott David J. | Director | Grant | A | 28.23 | 6,199 | 174,998 | 16,132 | 9.9 K to 16.1 K (+62.41 %) |
| Apr 26 2016 | ZLTQ | Zeltiq Aesthetics ... | Endicott David J. | Director | Grant | A | 0.00 | 9,933 | 0 | 9,933 | 0 to 9.9 K |
| Sep 03 2015 | HSP | HOSPIRA INC | Endicott David J. | Pres., Hospira Medi ... | Option Exercise | M | 43.01 | 72,971 | 3,138,483 | 0 | |
| Sep 03 2015 | HSP | HOSPIRA INC | Endicott David J. | Pres., Hospira Medi ... | Sell | D | 90.00 | 205,668 | 18,510,120 | 0 | 205.7 K to 0 (-100.00 %) |
| Sep 03 2015 | HSP | HOSPIRA INC | Endicott David J. | Pres., Hospira Medi ... | Buy | M | 43.01 | 72,971 | 3,138,483 | 205,668 | 132.7 K to 205.7 K (+54.99 %) |
| Sep 03 2015 | HSP | HOSPIRA INC | Endicott David J. | Pres., Hospira Medi ... | Grant | A | 0.00 | 15,196 | 0 | 132,697 | 117.5 K to 132.7 K (+12.93 %) |
| Jun 10 2015 | OREX | Orexigen Therapeut ... | Endicott David J. | Director | Option Exercise | A | 4.63 | 50,000 | 231,500 | 50,000 | |
| Feb 27 2015 | HSP | HOSPIRA INC | Endicott David J. | Pres., Hospira Medi ... | Grant | A | 87.50 | 40,000 | 3,500,000 | 117,501 | 77.5 K to 117.5 K (+51.61 %) |
| Feb 22 2013 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Option Exercise | A | 105.87 | 40,000 | 4,234,800 | 40,000 | |
| Feb 22 2013 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Payment of Exercise | F | 108.08 | 2,794 | 301,976 | 17,335 | 20.1 K to 17.3 K (-13.88 %) |
| Feb 20 2013 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Payment of Exercise | F | 108.02 | 225 | 24,305 | 20,129 | 20.4 K to 20.1 K (-1.11 %) |
| Nov 30 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Option Exercise | M | 64.47 | 52,560 | 3,388,543 | 1,940 | |
| Nov 30 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Sell | S | 92.43 | 52,560 | 4,857,974 | 20,352 | 72.9 K to 20.4 K (-72.09 %) |
| Nov 30 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Buy | M | 64.47 | 52,560 | 3,388,543 | 72,912 | 20.4 K to 72.9 K (+258.25 %) |
| May 09 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Option Exercise | M | 59.13 | 12,500 | 739,125 | 25,000 | |
| May 09 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Option Exercise | M | 40.16 | 15,000 | 602,400 | 15,000 | |
| May 09 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Sell | S | 93.81 | 27,500 | 2,579,750 | 20,352 | 47.9 K to 20.4 K (-57.47 %) |
| May 09 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Buy | M | 59.13 | 12,500 | 739,125 | 47,852 | 35.4 K to 47.9 K (+35.36 %) |
| May 09 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Buy | M | 40.16 | 15,000 | 602,400 | 35,352 | 20.4 K to 35.4 K (+73.70 %) |
| Feb 24 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Payment of Exercise | F | 87.27 | 212 | 18,501 | 20,352 | 20.6 K to 20.4 K (-1.03 %) |
| Feb 22 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Option Exercise | A | 87.91 | 15,000 | 1,318,650 | 15,000 | |
| Feb 22 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Option Exercise | A | 87.91 | 38,000 | 3,340,580 | 38,000 | |
| Feb 22 2012 | AGN | ALLERGAN INC | Endicott David J. | CVP and President, ... | Grant | A | 0.00 | 378 | 0 | 20,564 | 20.2 K to 20.6 K (+1.87 %) |
Page: 1